Immune response and drug therapy based on ac4c-modified gene in pancreatic cancer typing

HIGHLIGHTS

• who: Dong Xu and colleagues from the Southern Medical University, China have published the paper: Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing, in the Journal: (JOURNAL)
• what: The authors aimed to reveal the correlation between NAT10 expression levels and the clinical characteristics of pancreatic ductal adenocarcinoma patients.
• how: Subtypes in PDAC based on NAT10-relevant genes To narrow down the gene list and search for the prognosticationrelevant genes that were associated with NAT10 the authors conducted univariate analysis using Cox proportional hazard regression model in PDAC . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.